Dr. Eward on the Unmet Need for Novel Agents for TGCT and SarcomaByWilliam Eward, MD, DVMFebruary 14th 2020William Eward, MD, DVM, discusses the unmet need for novel agents in tenosynovial giant cell tumor and sarcoma.
Dr. Eward on FDA Approval of Pexidartinib in TGCTByWilliam Eward, MD, DVMOctober 30th 2019William Eward, MD, DVM, discusses the approval of pexidartinib to treat patients with tenosynovial giant cell tumor.